Results 341 to 350 of about 2,166,017 (392)

Oral Immunotherapy for Peanut Allergy

Annual Review of Medicine, 2016
Peanut allergy is a common disease and the cause of severe, life-threatening allergic reactions and death. It is rarely outgrown; most pediatric patients carry the disease into adulthood. Peanut allergy poses a significant burden on the quality of life of sufferers and their families, which results mainly from the fear of accidental peanut ingestion ...
Katherine, Anagnostou, Andrew, Clark
openaire   +2 more sources

pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy

Advances in Materials
mRNA vaccines for cancer immunotherapy are commonly delivered using lipid nanoparticles (LNPs), which, when administered intravenously, may accumulate in the liver, potentially limiting their therapeutic efficacy.
Po-Kai Luo, Hui‐Min Ho, Min-Chun Chiang, Li‐An Chu, Ya-Han Chuang, Ping-Chiang Lyu, I-Chen Hu, Wan-An Chang, Sheng-Yao Peng, Jayachandran Jayakumar, Hsin-Lung Chen, Ming-Hsi Huang, Hsing‐Wen Sung   +12 more
semanticscholar   +1 more source

Oral Immunotherapy for Food Allergy

Immunology and Allergy Clinics of North America, 2016
Food allergy is a potentially life-threatening condition with no approved therapies, apart from avoidance and injectable epinephrine for acute allergic reactions. Oral immunotherapy (OIT) is an experimental treatment in which food-allergic patients consume gradually increasing quantities of the food to increase their threshold for allergic reaction ...
Allison J, Burbank, Puja, Sood, Brian P, Vickery, Robert A, Wood   +3 more
openaire   +2 more sources

Oral immunotherapy for food allergy

Current Allergy and Asthma Reports, 2008
Current management of food allergy involves strict avoidance, education on recognizing and managing allergic reactions, and carrying an adrenaline autoinjector. This approach is burdensome and associated with reduced quality of life. Patients with food allergy would benefit greatly from a treatment that could achieve desensitization or long-term ...
openaire   +2 more sources

Oral Immunotherapy

Primary Care: Clinics in Office Practice, 2023
Krista Todoric, Sarah Merrill
openaire   +1 more source

Oral Immunotherapy and Potential Treatment

2015
The standardized therapeutic approach for food allergy is based on avoidance of allergens in foods. Oral immunotherapy (OIT) is a significant focus of food allergy research and appears to be effective in inducing desensitization. However, most patients receiving OIT have mild to moderate symptoms during the therapy, and it has not been clearly ...
Sakura, Sato, Noriyuki, Yanagida, Motohiro, Ebisawa   +2 more
openaire   +2 more sources

Oral immunotherapy

Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology, 2022
Noriyuki Yanagida, Masaki Futamura
openaire   +1 more source

Oral Immunotherapy: An Overview.

The Medical clinics of North America, 2023
Oral immunotherapy (OIT) is an alternative treatment of IgE-mediated food allergy that has been shown to increase tolerance threshold to many of the top food allergens, although this effect may be dependent on age, dose, frequency, and duration.
Krista, Todoric, Sarah, Merrill
openaire   +2 more sources

Oral immunotherapy in infants

Annals of Allergy, Asthma & Immunology, 2021
Hannah, Wangberg, Laura, Kuhlman, Kevin, Cook   +2 more
openaire   +2 more sources

First Oral Immunotherapy for Peanut Allergy

AJN, American Journal of Nursing, 2020
Peanut (Arachis hypogaea) allergen powder-dnfp (Palforzia) is the first oral immunotherapy for children ages four to 17 years who have been diagnosed with a peanut allergy.Like subcutaneous forms of immunotherapy, Palforzia introduces the allergen in increasing doses and risks inducing allergic responses, including ...
openaire   +2 more sources